We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Dapirolizumab pegol (DZP) met its primary endpoint, demonstrating statistically and clinically significant improvement across all organ systems as measured by BICLA, an endpoint measuring disease...
Phase 3 PHOENYCS GO study met the primary endpoint demonstrating clinical improvement in moderate-to-severe systemic lupus erythematosus; Clinical improvements were observed among key secondary...
UCB Convening Notice to the General Meeting of the Shareholders 2024 CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders for the ordinary...
SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today...
UCB Convocation à L’ Assemblée Générale des Actionnaires 2023 CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES Le Conseil d’Administration invite les actionnaires à l’assemblée générale...
BOSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, and UCB (EURONEXT BRUSSELS: UCB), a global...
UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022 Unofficial English translation – For convenience purposes only UCB SA/NV - Public Limited Liability CompanyAllée...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 5.9 | 3.2650802435 | 180.7 | 187.55 | 178.8 | 177280 | 185.1835395 | DE |
4 | 11.6 | 6.62857142857 | 175 | 190.2 | 175 | 203740 | 183.98430038 | DE |
12 | 23.85 | 14.6543778802 | 162.75 | 190.2 | 160.3 | 212883 | 176.71473256 | DE |
26 | 48.5 | 35.1194786387 | 138.1 | 190.2 | 133.95 | 217059 | 162.59385673 | DE |
52 | 110 | 143.603133159 | 76.6 | 190.2 | 75.86 | 255107 | 131.86044026 | DE |
156 | 90.14 | 93.4480613726 | 96.46 | 190.2 | 65.4 | 270090 | 97.75458005 | DE |
260 | 113.68 | 155.896873286 | 72.92 | 190.2 | 60.18 | 291244 | 94.21423855 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions